Skip to main content

Published locations for Crohn’s disease remission rates ‘remarkably higher’ with vedolizumab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Crohn’s disease remission rates ‘remarkably higher’ with vedolizumab

User login

  • Reset your password
  • /content/crohns-disease-remission-rates-remarkably-higher-vedolizumab
  • /fedprac/article/261709/gastroenterology/crohns-disease-remission-rates-remarkably-higher-vedolizumab
  • /gihepnews/article/261709/gastroenterology/crohns-disease-remission-rates-remarkably-higher
  • /internalmedicinenews/article/261709/gastroenterology/crohns-disease-remission-rates-remarkably
  • /internalmedicine/article/261709/gastroenterology/crohns-disease-remission-rates-remarkably-higher
  • /familymedicine/article/261709/gastroenterology/crohns-disease-remission-rates-remarkably-higher